Indivior Pharmaceuticals (INDV) Profit After Tax (QoQ) (2024 - 2026)
Indivior Pharmaceuticals (INDV) Profit After Tax (QoQ) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Indivior Pharmaceuticals | 5.00 Bn | 4.82 Bn | 277.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.75% |
| Dec 31, 2025 | 142.86% |
| Sep 30, 2025 | 133.33% |
| Jun 30, 2025 | -61.70% |
| Mar 31, 2025 | 123.81% |
| Dec 31, 2024 | -4.55% |
| Sep 30, 2024 | 122.68% |
| Jun 30, 2024 | -259.02% |